US Broker Ratings

Rocket Pharmaceuticals, Inc. (RCKT)

⚠️ No article content returned.

..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a 163.89% Potential Upside with Unique Therapeutics

Bicycle Therapeutics plc (NASDAQ: BCYC), a UK-based biotechnology company, has been making waves in the healthcare sector with its innovative approach to drug development. Specializing in..

Collegium Pharmaceutical (COLL) Stock Analysis: Unveiling the 111% Upside Potential

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector with a specific focus on pain management medications, positioning itself as a significant player in..

Embecta Corp. (EMBC) Stock Analysis: Navigating Healthcare’s Potential Amidst a -37.98% Forecasted Downside

Embecta Corp. (NASDAQ: EMBC), a seasoned player in the healthcare sector, has carved out a niche in the medical instruments and supplies industry by focusing on..

Akso Health Group (AHG) Stock Analysis: Navigating Uncharted Waters with an Innovative E-commerce Model

Investors are always on the lookout for unique opportunities, and Akso Health Group (NASDAQ: AHG) might just be one of those intriguing entities, especially for those..

Valneva SE (VALN) Stock Analysis: Is a 107% Upside Achievable?

Investors with a penchant for the healthcare sector might want to keep a close eye on Valneva SE (NASDAQ: VALN), a French biotechnology firm specializing in..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: Exploring a Potential 173% Upside with Promising Cancer Therapies

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is a burgeoning name in the biotechnology industry, focusing on developing innovative therapies for cancer treatment. Headquartered in New York, this..

Kura Oncology, Inc. (KURA) Stock Analysis: Biotech Innovator with a Promising 228% Upside Potential

Kura Oncology, Inc. (NASDAQ: KURA), a promising player in the biotechnology sector, is capturing the attention of investors with its robust pipeline of cancer treatments and..

InMode Ltd. (INMD) Stock Analysis: Exploring Growth Potential in the Medical Device Sector

InMode Ltd. (NASDAQ: INMD) is a noteworthy player in the healthcare sector, specializing in the medical devices industry. Headquartered in Yokne’am, Israel, the company is renowned..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a 101.48% Potential Upside in Biotechnology

Bicara Therapeutics Inc. (BCAX) is drawing significant attention from investors, given its compelling 101.48% potential upside. As a clinical-stage biopharmaceutical company, Bicara operates in the dynamic..

Taysha Gene Therapies (TSHA) Stock Analysis: Unveiling a 248% Potential Upside in a Promising Biotech Venture

Investors seeking opportunities in the high-risk, high-reward biotechnology sector may find Taysha Gene Therapies, Inc. (NASDAQ: TSHA) an intriguing candidate. With a market capitalization of $1.22..

Niagen Bioscience, Inc. (NAGE): Investor Outlook Reveals Potential 368% Upside

Niagen Bioscience, Inc. (NAGE), a player in the Consumer Defensive sector with a focus on the Packaged Foods industry, is attracting significant attention from investors due..

CeriBell, Inc. (CBLL): Investor Outlook on a Medical Device Innovator with Strong Buy Ratings

CeriBell, Inc. (CBLL), a healthcare trailblazer in the medical devices sector, has been garnering significant attention from investors, and for good reason. With a market capitalization..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Challenges with a Strategic Focus on Diagnostics

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling case for investors willing..

Xencor, Inc. (XNCR) Stock Analysis: Potential 30.9% Upside in Biotech Innovation

Xencor, Inc. (NASDAQ: XNCR) stands as a noteworthy player in the biotechnology industry, leveraging its expertise in engineered antibodies to address cancer and autoimmune diseases. As..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: A 20% Upside Potential in the Biotechnology Arena

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands at a critical juncture within the biotechnology sector, offering intriguing potential for investors seeking opportunities in life sciences. Operating..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a 98% Potential Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS), a prominent player in the healthcare sector, is making waves in the aesthetic beauty industry. The company, headquartered in Newport Beach, California,..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 33% Potential Upside in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV) is emerging as a compelling player within the healthcare sector, specifically focusing on medical care facilities. The company, with its unique..

Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a 40% Potential Upside in the Medical Device Market

Beta Bionics, Inc. (NASDAQ: BBNX), a burgeoning player in the healthcare sector, specifically in the medical devices industry, is capturing investor attention with a compelling growth..

Nutex Health Inc. (NUTX): Investor Outlook Shows Promising Upside with Strong Buy Ratings

Nutex Health Inc. (NASDAQ: NUTX) is capturing investor attention in the healthcare sector with its unique operational model and significant growth potential. Headquartered in Houston, Texas,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds